Skip to main content
Clinical Trials/JPRN-UMIN000040366
JPRN-UMIN000040366
Completed
未知

A prospective observational study of screening for MSI status in unresectable advanced gastric cancer: WJOG13320GPS - An observational study evaluating MSI status in unresectable advanced gastric cancer

West Japan Oncology Group0 sites1,000 target enrollmentMay 11, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
unresectable advanced gastric cancer
Sponsor
West Japan Oncology Group
Enrollment
1000
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 11, 2020
End Date
October 4, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Having concomitant active malignancies. 2\)Requiring systemic corticosteroid or immunosuppressant. 3\)History of prior anti\-PD\-1, anti\-PD\-L1, anti\-PD\-L2, anti\-CD137, anti\-CTLA\-4 antibody, or any other antibody which specifically targets T\-cell co\-stimulation or checkpoint pathways. 4\)Inappropriate judged by the investigators.

Outcomes

Primary Outcomes

Not specified

Similar Trials